17 January 2018
News and Views
Links and Services
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.
Dr William Sandborn and colleagues from California, USA performed the ulcerative
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors